Breast Cancer Clinical Trial
RCT Comparing ESPB Solutions in Breast Surgery
Summary
The object of our research is to investigate the relative efficacy of liposomal bupivacaine administered via an Erector Spinae Plane (ESP) block as compared to our standard of care medication solution of (bupivacaine mixed with epinephrine, dexamethasone, and clonidine) for pain management in subjects undergoing bilateral surgical intervention for breast cancer. This will be an investigator-initiated, double-blind, patient-controlled, randomized control trial comparing pain scores at 48 hours after injection.
Eligibility Criteria
Inclusion Criteria:
Adults 18 to 75 years of age at screening
Scheduled to undergo oncoplastic bilateral mastectomy and reconstruction surgery at Tufts Medical Center
Exclusion Criteria:
Adults unable to consent (inability to read, write, or has some impairment that hampers consent process or documentation, or cognitively impaired adults)
Pregnant women
Pregnant minors
Woman of childbearing potential who are unwilling or unable to complete a pregnancy test
Minors i.e., individuals who are not yet adults (neonates, children, teenagers)
Wards of the state
Non-viable neonates
Neonates of uncertain viability
Prisoners
Adults with known allergy, hypersensitivity, intolerance or contraindication to study medication
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Boston Massachusetts, 02111, United States More Info
Contact
How clear is this clinincal trial information?